Pablo F. Belaunzarán-Zamudio

Author

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ORCID

Also Known As

Belaunzarán-Zamudio, Pablo F., Brenda Crabtree Ramirez, Francisco Belaunzarán-Zamudio, Franciso Belaunzarán-Zamudio, P F Belaunzaran-Zamudio, P. F. Belaunzarán-Zamudio, P.F. Belaunzarán-Zamudio, PF Belaunzaran‐Zamudio, PF Belaunzarán‐Zamudio, Pablo Belaunzaran-Zamudio

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán National Institute of Allergy and Infectious Diseases Fundação Oswaldo Cruz Instituto Evandro Chagas Universidad Peruana Cayetano Heredia

About

Pablo F. Belaunzarán-Zamudio is an author at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán specializing in medicine, hiv, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	346
2	Public Health	6	6	237
3	Epidemiology	5	5	201
4	Health Sciences	2	2	73
5	Allergy	1	1	45

Pablo F. Belaunzarán-Zamudio

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico Braulio A. Marfil‐Garza, Pablo F. Belaunzarán-Zamudio, Alfonso Gulı́as-Herrero, PLoS ONE	2018	101
High prevalence of late diagnosis of HIV in Mexico during the HAART era Brenda Crabtree‐Ramírez, Yanink Caro-Vega, Pablo F. Belaunzarán-Zamudio, Salud Pública de México	2012	81
Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study Casey Smiley, Peter F. Rebeiro, Carina César, The Lancet HIV Sexual HealthEpidemiological TrendEpidemiological OutcomeTreatment And PreventionLatin American Society	2021	70
Prospective, Randomized, Open Label Trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ Treatment-Naive Subjects With CD4+<200 cell/mm3 in Mexico Juan Sierra‐Madero, Angelina Villası́s-Keever, Patricia Méndez, JAIDS Journal of Acquired Immune Deficiency Syndromes	2010	62
Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome Supriya Ravichandran, Megan Hahn, Pablo F. Belaunzarán-Zamudio, Nature Communications	2019	56
Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial Juan Sierra‐Madero, Susan S. Ellenberg, Mohammed Rassool, The Lancet HIV InflammationCcr5 Antagonist MaravirocAutoimmune DiseaseTreatment And PreventionImmunology	2014	55
Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART Pablo F. Belaunzarán-Zamudio, Miguel Leonardo García-León, Rosa María Wong‐Chew, Vaccine VaccinationMeasles AntibodiesVaccine DevelopmentImmunologyVaccine Testing	2009	48
The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America Pablo F. Belaunzarán-Zamudio, Yanink Caro-Vega, Bryan E. Shepherd, American Journal of Epidemiology ImmunodeficienciesPopulation Health SciencesLatin AmericaLogistic AnalysisHiv/aids Counselling	2019	48
Vitamin D, d -dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International Study Laura W. Musselwhite, Bruno B. Andrade, Susan S. Ellenberg, EBioMedicine ImmunodeficienciesImmunologyScd14 LevelsImmune SystemLogistic Analysis	2016	45
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1 Jeffrey M. Jacobson, Steven E. Bosinger, Minhee Kang, AIDS Research and Human Retroviruses Immune ActivationTlr LigandsImmune RegulationImmunologyAntiviral Drug	2016	41

Page 1